GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $0.87 $1.65 Thursday, 18th Apr 2024 ADAP stock ended at $0.90. This is 8.98% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 13.44% from a day low at $0.87 to a day high of $0.99.
90 days $0.691 $2.05
52 weeks $0.420 $2.05

Historical Adaptimmune Therapeutics plc prices

Date Open High Low Close Volume
2023-12-29 $0.689 $0.84 $0.689 $0.793 1 282 072
2023-12-28 $0.759 $0.759 $0.620 $0.690 1 348 011
2023-12-27 $0.590 $0.724 $0.590 $0.719 1 641 869
2023-12-26 $0.504 $0.620 $0.501 $0.584 1 493 859
2023-12-22 $0.480 $0.502 $0.473 $0.500 695 518
2023-12-21 $0.440 $0.473 $0.430 $0.473 754 937
2023-12-20 $0.460 $0.497 $0.440 $0.441 770 651
2023-12-19 $0.446 $0.495 $0.435 $0.460 1 080 108
2023-12-18 $0.458 $0.460 $0.432 $0.450 1 139 498
2023-12-15 $0.481 $0.497 $0.450 $0.450 1 512 668
2023-12-14 $0.490 $0.514 $0.482 $0.488 548 472
2023-12-13 $0.500 $0.510 $0.482 $0.509 391 831
2023-12-12 $0.500 $0.528 $0.491 $0.495 341 046
2023-12-11 $0.522 $0.530 $0.495 $0.503 426 793
2023-12-08 $0.532 $0.561 $0.530 $0.545 263 091
2023-12-07 $0.580 $0.580 $0.525 $0.570 336 074
2023-12-06 $0.568 $0.589 $0.555 $0.562 769 095
2023-12-05 $0.557 $0.600 $0.500 $0.561 760 576
2023-12-04 $0.530 $0.598 $0.490 $0.529 613 328
2023-12-01 $0.471 $0.548 $0.471 $0.542 333 805
2023-11-30 $0.490 $0.516 $0.471 $0.500 220 154
2023-11-29 $0.446 $0.508 $0.440 $0.498 285 707
2023-11-28 $0.469 $0.480 $0.421 $0.446 362 270
2023-11-27 $0.470 $0.480 $0.447 $0.475 425 760
2023-11-24 $0.449 $0.470 $0.433 $0.465 367 051
Click to get the best stock tips daily for free!

About Adaptimmune Therapeutics plc

Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4 that is in phase II clinical trials with SPEARHEAD-1 for synovial sarcoma and myxoid round cell liposa... ADAP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT